Unknown

Dataset Information

0

Anti-SARS-CoV-2 Repurposing Drug Database: Clinical Pharmacology Considerations.


ABSTRACT: A critical step to evaluate the potential in vivo antiviral activity of a drug is to connect the in vivo exposure to its in vitro antiviral activity. The Anti-SARS-CoV-2 Repurposing Drug Database is a database that includes both in vitro anti-SARS-CoV-2 activity and in vivo pharmacokinetic data to facilitate the extrapolation from in vitro antiviral activity to potential in vivo antiviral activity for a large set of drugs/compounds. In addition to serving as a data source for in vitro anti-SARS-CoV-2 activity and in vivo pharmacokinetic information, the database is also a calculation tool that can be used to compare the in vitro antiviral activity with in vivo drug exposure to identify potential anti-SARS-CoV-2 drugs. Continuous development and expansion are feasible with the public availability of this database.

SUBMITTER: Zhang X 

PROVIDER: S-EPMC8420371 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC9052367 | biostudies-literature
| S-EPMC8186476 | biostudies-literature
| S-EPMC8579950 | biostudies-literature
| S-EPMC8001969 | biostudies-literature
| S-EPMC8501941 | biostudies-literature
| S-EPMC5838628 | biostudies-literature
| S-EPMC8830191 | biostudies-literature
| S-EPMC8779140 | biostudies-literature
| S-EPMC7263255 | biostudies-literature
| S-EPMC7360763 | biostudies-literature